Efficacy of probiotics in preventing late-onset sepsis in very low birth weight infants: a Meta analysis.
- Author:
Jie-Yong LI
1
;
Zhi-Xun HE
1
;
Wei-Ming WANG
1
;
Cai LIN
1
Author Information
1. Department of Neonatology, First People's Hospital of Zhaoqing, Zhaoqing, Guangdong 526000, China.
- Publication Type:Meta-Analysis
- MeSH:
China;
Female;
Humans;
Infant;
Infant, Newborn;
Infant, Premature;
Infant, Very Low Birth Weight;
Probiotics/therapeutic use*;
Sepsis/prevention & control*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(6):599-607
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the efficacy of probiotics in preventing late-onset sepsis (LOS) in very low birth weight (VLBW) infants.
METHODS:Databases including PubMed, Web of Science, Cochrane Library, Wanfang Data, China National Knowledge Infrastructure, and Chinese Biomedical Literature Database were searched for randomized controlled trials (RCTs) of probiotics in preventing LOS in VLBW infants. LOS was classified as clinical LOS and confirmed LOS. RevMan 5.4 was used to perform the Meta analysis.
RESULTS:A total of 31 RCTs were included, with 3 490 VLBW infants in the probiotics group and 3 376 VLBW infants in the control group. The Meta analysis showed that compared with the control group, the probiotics group had significantly lower risks of clinical LOS (
CONCLUSIONS:Current evidence indicates that probiotics may reduce the risk of clinical LOS and clinical/confirmed LOS in VLBW infants, and the risk of confirmed LOS in VLBW infants who are exclusively breastfed.
